ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,937 | +1.0% | 57,611 | +19.8% | 0.00% | – |
| Q2 2023 | $44,471 | +32.7% | 48,077 | +56.4% | 0.00% | – |
| Q1 2023 | $33,512 | -83.7% | 30,745 | -78.2% | 0.00% | – |
| Q4 2022 | $205,713 | -57.1% | 140,899 | -68.4% | 0.00% | – |
| Q3 2022 | $479,000 | -22.2% | 445,193 | +22.9% | 0.00% | – |
| Q2 2022 | $616,000 | -16.9% | 362,101 | +0.6% | 0.00% | – |
| Q1 2022 | $741,000 | -36.0% | 359,919 | +16.7% | 0.00% | – |
| Q4 2021 | $1,157,000 | -32.3% | 308,511 | -6.6% | 0.00% | – |
| Q3 2021 | $1,708,000 | +5.2% | 330,378 | -13.3% | 0.00% | – |
| Q2 2021 | $1,624,000 | +549.6% | 381,161 | +708.6% | 0.00% | – |
| Q1 2021 | $250,000 | -9.1% | 47,138 | -7.7% | 0.00% | – |
| Q4 2020 | $275,000 | -94.1% | 51,048 | -91.3% | 0.00% | -100.0% |
| Q3 2020 | $4,680,000 | +6.6% | 586,443 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $4,391,000 | +8184.9% | 438,670 | +1141.0% | 0.00% | – |
| Q3 2019 | $53,000 | -54.3% | 35,348 | +23.0% | 0.00% | – |
| Q2 2019 | $116,000 | -52.3% | 28,745 | -49.2% | 0.00% | – |
| Q1 2019 | $243,000 | +19.7% | 56,582 | +59.9% | 0.00% | – |
| Q4 2018 | $203,000 | -43.1% | 35,381 | +34.6% | 0.00% | – |
| Q3 2018 | $357,000 | -27.3% | 26,293 | -36.4% | 0.00% | – |
| Q2 2018 | $491,000 | -21.4% | 41,344 | -25.7% | 0.00% | – |
| Q1 2018 | $625,000 | +7.0% | 55,657 | -36.3% | 0.00% | – |
| Q4 2017 | $584,000 | +43.8% | 87,392 | +76.2% | 0.00% | – |
| Q3 2017 | $406,000 | +782.6% | 49,600 | +383.9% | 0.00% | – |
| Q2 2017 | $46,000 | -71.2% | 10,251 | -47.6% | 0.00% | – |
| Q2 2016 | $160,000 | – | 19,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |